Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	340.24	234.21	249.77	150.48	187.24
Short-Term Investments	402.84	315.8	101.68	37.78	81.15
Cash & Short-Term Investments	743.08	550.01	351.45	188.26	268.39
Cash Growth	35.10%	56.50%	86.69%	-29.86%	96.77%
Prepaid Expenses	27.3	9.95	3.72	5.32	2.96
Total Current Assets	770.38	559.96	355.17	193.58	271.35
Property, Plant & Equipment	0.76	1.03	1.29	1.55	1.79
Long-Term Investments	54.75	19.28	-	-	-
Other Long-Term Assets	-	-	0.11	0.42	0.2
Total Assets	825.89	580.27	356.57	195.55	273.34
Accounts Payable	9.03	7.04	7.97	6.71	3.43
Accrued Expenses	30.1	11.57	10.79	18.22	9.39
Current Portion of Leases	0.29	0.52	0.33	0.21	0.29
Other Current Liabilities	0.34	-	-	-	-
Total Current Liabilities	39.75	19.13	19.08	25.13	13.11
Long-Term Debt	35.3	24.96	9.54	-	-
Long-Term Leases	0.53	0.82	1.08	1.31	1.52
Other Long-Term Liabilities	0.19	0.05	0.31	-	-
Total Liabilities	75.77	44.97	30.01	26.44	14.63
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,575	1,109	748.86	479.44	468.24
Retained Earnings	-826.16	-574.1	-422.34	-310.3	-209.53
Comprehensive Income & Other	0.95	0.27	0.04	-0.03	-0
Total Common Equity	750.11	535.31	326.56	169.11	258.71
Shareholders' Equity	750.11	535.31	326.56	169.11	258.71
Total Liabilities & Equity	825.89	580.27	356.57	195.55	273.34
Total Debt	36.12	26.31	10.95	1.52	1.81
Net Cash (Debt)	761.71	542.99	340.5	186.74	266.58
Net Cash Growth	40.28%	59.47%	82.34%	-29.95%	95.56%
Net Cash Per Share	11.35	10.33	8.73	5.36	8.47
Filing Date Shares Outstanding	79.62	56.3	46.97	35.01	34.77
Total Common Shares Outstanding	72.38	55.75	46.87	34.9	34.74
Working Capital	730.63	540.83	336.09	168.45	258.23
Book Value Per Share	10.36	9.60	6.97	4.85	7.45
Tangible Book Value	750.11	535.31	326.56	169.11	258.71
Tangible Book Value Per Share	10.36	9.60	6.97	4.85	7.45

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q